Probuphine is the reason why I bought so many shares between .02-.05 :)
Quoted from Titan's website..."For many of the same reasons that Probuphine offers potential advantages for opioid addiction, it is a promising candidate for the potential treatment of chronic pain, which represents a larger patient population than opioid addiction and a significant unmet medical need. Buprenorphine is currently approved for the treatment of chronic pain in Europe, primarily utilizing a patch formulation. Probuphine’s long-term delivery and stable blood levels of drug may provide certain advantages in potential treatment of chronic pain."
I'd say it gets approval for opioid addiction with no problems. IF and it's a big if chronic pain is added to it :P
I've sold a small amount of shares to reap profits but not on the first two jumps to 1.50+
I will not sell and will buy more if it falls, waiting for news with Phase 3, Vanda buyout or partnership. I'm in a new tax bracket already and I'll break through another one if I were to sell. (LOL)
Market Data 
Markets 
AI
